{
  "docId": "019de073-7e4e-7689-a01c-e0840dac2b61",
  "docSlug": "97e34d6c4db7d9454440fee3efd43545",
  "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides",
  "authorId": "axcella-health",
  "authorName": "Axcella Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 29,
  "pageCount": 62,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "other",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide presents preclinical data from primary human hepatic stellate cells.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/29",
  "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61",
  "deckJsonHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61.json",
  "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-29",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.45,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Decreases in Collagen Deposition Measured with AXA1125",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b8f30a9-1127-4318-a07e-8655e915219a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.45,
        "x": 0.52,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Reduced Fibrogenic Activation & Proliferation",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d73dba4-681e-4476-a03a-ffe7aae1a163",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.95,
        "x": 0.03,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1. Daou et al. Nat Sci Rep. 2021. ***p < 0.001 versus TGF-β1, Data from Primary Human Hepatic Stellate Cells pre-treated with LIVRQNac for 24 hours, then stimulated with 3.3ng/ml TGF-β1 for 24 hours, EdU data normalized to nuclei, HSP47 expression normalized to GAPDH, other data not nuclei normalized.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6479baa8-19c8-453f-9d15-e0b1e3e27c13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "AXA1125 Decreases Fibrosis Activation, Proliferation, and Collagen Deposition",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca147238-fe9c-4006-838c-954e667a9c2e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Multi-targeted impact on fibrosis improvement: Reduced Activation, Proliferation, Deposition",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4edcd52-57d6-4c1f-a79d-76bed28a0d09",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chartjunk Elimination",
      "slug": "chartjunk-elimination",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "56ee7a13-2c6a-455e-b961-942b50d6ba7f",
      "evidence": "chart/line: Decreases in Collagen Deposition Measured with AXA1125 and chart/line: Reduced Fibrogenic Activation & Proliferation",
      "confidence": 0.7
    },
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "72518385-9808-45ed-b997-522f202aebe6",
      "evidence": "title/headline: AXA1125 Decreases Fibrosis Activation, Proliferation, and Collagen Deposition",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 36,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d",
      "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression",
      "position": 0,
      "objective": "What is the risk of not treating NASH effectively?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 30,
      "from": 24,
      "name": "Value Chain Walk",
      "slug": "44-value-chain-walk",
      "bestFor": "Operations improvement, cost reduction, competitive advantage",
      "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26",
      "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways",
      "position": 1,
      "objective": "How does AXA1125 address the complex disease pathways of NASH?",
      "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment",
      "confidence": 0.6,
      "description": "Walk through each step of the value chain to identify where value is created or destroyed"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}